{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:36:02Z","timestamp":1766504162741,"version":"3.41.2"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["98649"],"award-info":[{"award-number":["98649"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The overall prevalence of antimicrobial therapy (AMT) in nursing homes is well described. However, less is known about the appropriateness of AMT in nursing home residents. Therefore, the Check of APpropriaTeness of antimicrobial therapy in nursing homes (CAPTAIN) study aimed to assess both prevalence and appropriateness of AMT in Belgian nursing homes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In a prospective, observational, point prevalence study, researchers documented prevalence and identified potentially inappropriate prescriptions (PIPs) by evaluating accordance of AMT with national guidelines. The severity of inappropriateness was assessed by a modified Delphi expert panel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Eleven nursing homes, including 1178 residents, participated in this study. On the survey day, 8.0% of residents took systemic AMT, primarily for urinary tract infections (54.2%), respiratory tract infections (36.5%), and skin and skin-structure infections (6.3%). About half of these prescriptions were used in prophylaxis (52.1%). Registration of indication and stop date was missing in 58.3% and 56.3% of AMTs, respectively. In 89.6% of the systemic AMTs, at least one discordance with national guidelines was identified, resulting in a total of 171 PIPs, with 49 unique PIPs. Of all unique PIPs, 26.5% were assessed with a high severity score (\u22654). According to the expert panel, most inappropriate practice was starting AMT for cough without other symptoms. Inappropriate timing of time-dependent AMTs was common, but assessed as \u2018moderately severe\u2019. One-third of systemic AMT exceeded the recommended duration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>AMT in nursing homes is often not prescribed according to national guidelines, highlighting the need for future interventions to promote the rational use of AMT in this setting.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlae101","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T13:10:24Z","timestamp":1720271424000},"source":"Crossref","is-referenced-by-count":2,"title":["Check of APpropriaTeness of Antimicrobial therapy In Nursing homes (CAPTAIN):a point prevalence study in Belgium"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4772-0542","authenticated-orcid":false,"given":"Indira","family":"Coenen","sequence":"first","affiliation":[{"name":"KU Leuven, Department of Pharmaceutical and Pharmacological Sciences , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte","family":"Vander Elst","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven, Pharmacy Department , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6342-0676","authenticated-orcid":false,"given":"Isabel","family":"Spriet","sequence":"additional","affiliation":[{"name":"KU Leuven, Department of Pharmaceutical and Pharmacological Sciences , Leuven , Belgium"},{"name":"University Hospitals Leuven, Pharmacy Department , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1378-3772","authenticated-orcid":false,"given":"Matthias","family":"Gijsen","sequence":"additional","affiliation":[{"name":"KU Leuven, Department of Pharmaceutical and Pharmacological Sciences , Leuven , Belgium"},{"name":"University Hospitals Leuven, Pharmacy Department , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-3915","authenticated-orcid":false,"given":"Veerle","family":"Foulon","sequence":"additional","affiliation":[{"name":"KU Leuven, Department of Pharmaceutical and Pharmacological Sciences , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6152-2134","authenticated-orcid":false,"given":"Jan","family":"De Lepeleire","sequence":"additional","affiliation":[{"name":"KU Leuven, Department of Public Health and Primary Care , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9113-7712","authenticated-orcid":false,"given":"Katrien","family":"Latour","sequence":"additional","affiliation":[{"name":"KU Leuven, Department of Public Health and Primary Care , Leuven , Belgium"},{"name":"Sciensano, Department of Epidemiology and Public Health , Brussels , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-1974","authenticated-orcid":false,"given":"Veerle","family":"Cossey","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven, Department of Infection Control and Epidemiology , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Schuermans","sequence":"additional","affiliation":[{"name":"KU Leuven, Department of Public Health and Primary Care , Leuven , Belgium"},{"name":"University Hospitals Leuven, Department of Infection Control and Epidemiology , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nele","family":"Stroobants","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven, Department of Infection Control and Epidemiology , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6072-2596","authenticated-orcid":false,"given":"Charlotte","family":"Quintens","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven, Pharmacy Department , Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"volume-title":"Antimicrobial Resistance in Long-term Care Facilities","year":"2022","author":"Eze","key":"2024083008103744100_dlae101-B1"},{"key":"2024083008103744100_dlae101-B2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"2024083008103744100_dlae101-B3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41429-023-00629-8","article-title":"Antibiotics in the clinical pipeline as of December 2022","volume":"76","author":"Butler","year":"2023","journal-title":"J Antibiot (Tokyo)"},{"key":"2024083008103744100_dlae101-B4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13690-022-00818-1","article-title":"Healthcare-associated infections and antimicrobial use in Belgian nursing homes: results of three point prevalence surveys between 2010 and 2016","volume":"80","author":"Latour","year":"2022","journal-title":"Arch Public Health"},{"volume-title":"Puntprevalentiestudie van zorginfecties en antimicrobieel gebruik in chronische zorginstellingen (HALT-2021)","year":"2022","author":"Int Panis","key":"2024083008103744100_dlae101-B5"},{"author":"Pilootproject \u201cHospital Outbreak Support Teams\u201d (HOST)","key":"2024083008103744100_dlae101-B6"},{"author":"HOST Plexus","key":"2024083008103744100_dlae101-B7"},{"key":"2024083008103744100_dlae101-B8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/501875","article-title":"Development of minimum criteria for the initiation of antibiotics in residents of long-term care facilities: results of a consensus conference","volume":"22","author":"Loeb","year":"2001","journal-title":"Inf Control Hosp Epi"},{"author":"Belgian Antibiotic Coordination Committee (BAPCOC)","key":"2024083008103744100_dlae101-B9"},{"key":"2024083008103744100_dlae101-B10"},{"author":"Medscape","key":"2024083008103744100_dlae101-B11"},{"author":"DelphiCare drug database.","key":"2024083008103744100_dlae101-B12"},{"key":"2024083008103744100_dlae101-B13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/ebnurs-2020-103303","article-title":"What are Delphi studies?","volume":"23","author":"Barrett","year":"2020","journal-title":"Evid Based Nurs"},{"key":"2024083008103744100_dlae101-B14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/pds.1980","article-title":"How are antibacterials used in nursing homes? Results from a point prevalence prescription study in 44 Norwegian nursing homes","volume":"19","author":"Blix","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024083008103744100_dlae101-B15","first-page":"1025","article-title":"Infections and antibiotic prescribing in Swedish nursing homes: a cross-sectional study","volume":"19","author":"Pettersson","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"2024083008103744100_dlae101-B16","doi-asserted-by":"crossref","first-page":"e015233","DOI":"10.1136\/bmjopen-2016-015233","article-title":"Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and meta-analysis of randomised trials","volume":"7","author":"Ahmed","year":"2017","journal-title":"BMJ Open"},{"key":"2024083008103744100_dlae101-B17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1473-3099(18)30279-2","article-title":"Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial","volume":"18","author":"Fisher","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024083008103744100_dlae101-B18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/CMR.00112-16","article-title":"Current and emerging topical antibacterials and antiseptics: agents, action, and resistance patterns","volume":"30","author":"Williamson","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"2024083008103744100_dlae101-B19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12877-019-1181-4","article-title":"Asymptomatic bacteriuria in older adults: the most fragile women are prone to long-term colonization","volume":"19","author":"Biggel","year":"2019","journal-title":"BMC Geriatr"},{"key":"2024083008103744100_dlae101-B20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/antibiotics11070889","article-title":"Why we may need higher doses of beta-lactam antibiotics: introducing the \u2018maximum tolerable dose\u2019","volume":"11","author":"Dhaese","year":"2022","journal-title":"Antibiotics"},{"key":"2024083008103744100_dlae101-B21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/M19-1509","article-title":"Duration of antibiotic therapy: shorter is better","volume":"171","author":"Spellberg","year":"2019","journal-title":"Ann Intern Med"},{"key":"2024083008103744100_dlae101-B22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jac\/dkab364","article-title":"The effectiveness of check of medication appropriateness for antimicrobial stewardship: an interrupted time series analysis","volume":"77","author":"Quintens","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2024083008103744100_dlae101-B23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.18773\/austprescr.2019.066","article-title":"The 2018 aged care national antimicrobial prescribing survey: results show room for improvement","volume":"42","author":"Dowson","year":"2019","journal-title":"Aust Prescr"},{"author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","key":"2024083008103744100_dlae101-B24"},{"author":"National Institute for Health and Care Excellence","key":"2024083008103744100_dlae101-B25"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/6\/4\/dlae101\/58875544\/dlae101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/6\/4\/dlae101\/58875544\/dlae101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T12:40:03Z","timestamp":1725021603000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlae101\/7708667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlae101","relation":{},"ISSN":["2632-1823"],"issn-type":[{"type":"electronic","value":"2632-1823"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,7,3]]},"article-number":"dlae101"}}